Castle Biosciences, Inc. (CSTL)
35.36
-0.20
(-0.56%)
USD |
NASDAQ |
Oct 05, 13:19
Castle Biosciences Enterprise Value : 854.73M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 854.73M |
| October 01, 2026 | 845.42M |
| September 30, 2026 | 853.81M |
| September 29, 2026 | 833.98M |
| September 28, 2026 | 866.02M |
| September 25, 2026 | 862.35M |
| September 24, 2026 | 843.44M |
| September 23, 2026 | 833.98M |
| September 22, 2026 | 833.07M |
| September 21, 2026 | 837.34M |
| September 18, 2026 | 848.02M |
| September 17, 2026 | 891.95M |
| September 16, 2026 | 852.29M |
| September 15, 2026 | 852.90M |
| September 14, 2026 | 790.05M |
| September 11, 2026 | 756.18M |
| September 10, 2026 | 755.88M |
| September 09, 2026 | 755.57M |
| September 08, 2026 | 769.30M |
| September 04, 2026 | 773.88M |
| September 03, 2026 | 765.95M |
| September 02, 2026 | 789.44M |
| September 01, 2026 | 790.05M |
| August 31, 2026 | 777.54M |
| August 28, 2026 | 791.88M |
| Date | Value |
|---|---|
| August 27, 2026 | 815.07M |
| August 26, 2026 | 809.57M |
| August 25, 2026 | 837.64M |
| August 24, 2026 | 790.96M |
| August 21, 2026 | 813.24M |
| August 20, 2026 | 774.49M |
| August 19, 2026 | 755.88M |
| August 18, 2026 | 655.51M |
| August 17, 2026 | 683.57M |
| August 14, 2026 | 673.51M |
| August 13, 2026 | 701.88M |
| August 12, 2026 | 728.73M |
| August 11, 2026 | 753.44M |
| August 10, 2026 | 756.80M |
| August 07, 2026 | 747.03M |
| August 06, 2026 | 699.44M |
| August 05, 2026 | 697.30M |
| August 04, 2026 | 721.10M |
| August 03, 2026 | 697.00M |
| July 31, 2026 | 624.08M |
| July 30, 2026 | 587.17M |
| July 29, 2026 | 516.08M |
| July 28, 2026 | 498.69M |
| July 27, 2026 | 515.47M |
| July 24, 2026 | 522.95M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| RadNet, Inc. | 7.255B |
| Lumexa Imaging Holdings, Inc. | 1.897B |
| Quest Diagnostics, Inc. | 31.81B |
| Labcorp Holdings, Inc. | 31.60B |
| OPKO Health, Inc. | 1.261B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.06M |
| Revenue (Quarterly) | 103.55M |
| Total Expenses (Quarterly) | 105.61M |
| EPS Diluted (Quarterly) | -0.0678 |
| Gross Profit Margin (Quarterly) | 74.29% |
| Profit Margin (Quarterly) | -1.99% |
| Earnings Yield | -1.84% |
| Normalized Earnings Yield | -2.017 |